Tag: Omission of Risk Information

CHC_DTCadvertisement2

04/18/2022

Presentation of Risks in DTC Video, HCP Webpage Yields Enforcement Letter for Bausch Health

socialmedia.news (1)

01/31/2022

OPDP Cites Lilly for Omission of Risk Info in Trulicity Instagram Post

CHC_DTCadvertisement2

01/17/2022

OPDP, Lilly Come to Terms Over TV Ads for Migraine Drug

FDA-News (1)

08/30/2021

OPDP Enforcement Letter to Eton Pharmaceuticals Cites Omission of Risk Info in Sponsored Links

CHC_FDA-Regulatory Images1

10/07/2019

OPDP Cites Risk Presentation Issues in YouTube Video, Email in New Enforcement Letters

CHC_FDA-Regulatory Images1

09/09/2019

OPDP Warning Letter: Omission of Risk Info in DTC Print Ad/Display Banners Misbrands ED Drug

CHC_FDA-Regulatory Images1

08/05/2019

Latest OPDP Enforcement Letters: Don’t Omit or Distract from Risk Information

CHC_general1

11/02/2018

OPDP Cites Lack of Risk Information in Second Warning Letter of 2018

CHC_FDA-Regulatory Images1

11/30/2017

OPDP’s Third Enforcement Letter of 2017 Cites Presentation of Risks, Efficacy Claims